4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-25-228340
Co-Chief Executive Officer sold 29,933 shares at an average $14.35 ($429,469)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Joshua B Co-Chief Executive Officer | 2025-09-30 | Sale | −29,733 | $14.34 | $426,469 | 3,325,547 | D |
| Cohen Joshua B Co-Chief Executive Officer | 2025-09-30 | Sale | −200 | $15.00 | $3,000 | 3,325,347 | D |
| Open-market sales · 29,933 sh · avg $14.35 · $429,469 | |||||||
Loading xslF345X05/ownership.xml…